ارتباط بین بیماری ویتیلیگو و گروههای خونی A B O و Rh - مجله علمی دانشگاه علوم پزشکی بیرجند

A B O Rh

:

! "# $

:

%

&

% ( .

*+

,

! -.

/ 0 1 2 3

4 5

6 7 6, "#

. 0 ,(6 *8 9

:

. ! 0 /, *;

9 <

0

=*>

?(

( .

< >

*@ A B(, C . D E.!

C /, *;

0 3

A

3

B O

F G

Rh

( .

!

:

< > C

!

% 0(, 3

*8 /, *;

0 !

Rh

HH E ! )

! ? *;

(

HH

*8 7 *2 K

E *

? * ,

!

3( ? * * (6 * */ 0 /, ! (

)

? *;

(, ( (6 8*; ! *L < > ! .

? *;

. ? *; *, !

Rh

( C

*8 ? *; *,

!

" !

E K *8

*

! E

M 8*; ! *L .

? F* 7 ? 2 , 0! # ! N8

0 / 7#

SPSS

Chi-Square

6 O> !

t

0!

PQ / P (6 8*; ! *L S T. NG. !

P

.

? *;

:

&

% 7 E

"

3

3

A

% 3

B

U

%

&V

AB

% .

O

(, ? *; ! 3

(4!

C

, *;

0 / .*.

W X

% 3

&

% 3

%

&

%

1 8 C

0! # *+ 7 6

! ) HY / H

P<

3 ZQ / [

2

= .(

!

Rh

VU

%

! ? *; 7 V

% 7 (, ? *;

3 E]

!

%

! ? *; 7 U

% 7 (, ? *;

3 26 ^ C

6 0! # *+ 7 B E !

) HY / H

P>

3 ZQ / [

2

= (.

8

:

,

< > C 0

" _

? *; *8 0 /, *; * E

B

3 0 *

0!

*.(

(6

<

C

! 0 6 > !

Rh

! 0

! ( .

^

:

, *;

0 /

^

Rh ) )*

! )

# $ " !

%&+

(

,- . : 0 / 2 /

%&0 . " 345

: 2 / /

%&0 6 .7

: 8' / /

%&0

(6 * ` N F 5 ? _ 3 ` N ?(`_ 3 7 # ? *; ! _ ^ a ?(6

b! # : (6 *

% 0! 2K "

%

*d5 < " ! )

e5 (

% fg

C2 . : XXX HH

% HYh

* : XX HHX

% HYh

` * `<

rezaghaderi@yahoo.com:

&

? _ 7#

DNA Typing 3

(/_ L ` N

X i< 7

Vitelius

6 j _ < ;

?(

. 2 D M ( :<

, 0 2

! ( 0

E < ;

( ! ,

.

* . *+ 7 2

" 7

! ,

F!(

k g = >

/ 8 0 lg_ "( *

C:

! 0 . ( "

) .(

< * _ 1 < >

0 ,(6 *8 9

:

"# !

, 9

( .

! 0 , L ! 0

: g. .

: g. 7 f

?( ?(, _ .

! .

; mg

! SL (A E]

H

%

! 8 )

(.

! < >

0

?*G , 0 i n 2 W< K 7 . "9 $

! *

=*>

) 3&

(.

(A

% 7 E "# *8 (

$

6

* * 0 ( ! .

! YH

% 7 SEL !

<

*, o

( .

"

@ ( .

< * 9 ( ?N ) .(

D E.!

/, *; C 0

p g 3 A B O

! / 0 p g

!* !

8*; ! *L

" * _, q G

8 6 7 C !

( " 65 ^

]

? *; ! ?( r 7

? *; , 7 r 7 A

D E.! ! O

) X (.

D E.! 6 7 ! C

/, *;

0 N

?( F G 2 g 1 < >

. 1 2 e .

! * !

sL 6 ) Y

% X ( C . B(, *@ A < > 3

D E.!

C /, *;

0 )

3 A B

( O Rh

( F G .

!

C !

< >

!

% 0(, 3 ( HH 7 *2

*

" ;(66

0 /, !

ddg.

*/

(6 *

! 0

ldg t .

g_. / # ! l

?( ? 3

u g )

! ( . /

? *; C N *

" M ( ( ? *8 (6 *

.

*8 C 7 ? * ,

" ! N HH *2

" 7# ? *; v6 C *+ 7

(, ? *; " 65 3( " , ( u g

(

! vw

7# T. N * "#

. f

? *; C (6 8*; ! *L

.

? *; *8 *, 1 dg_

0 Rh

* 8 *, !

:2.

Ex (, " 7# ? *;

( .

/. 6_ *

! ?(

"#

t .

ddg C

! #

?( ( . 3

1 5 k b *

4 A S `.

( .

? y 0 , 0! z;( 7 v 3?( 0! #

F* 7 ? 2 0! # ! N8

0! # 0 / 7# SPSS t

Chi-Sqaure

6 O> ! 0!

PQ /

P P NG. !

(6 8*; ! *L S T.

.

"

#

$ 7 HH

*2

! E 3

YH

* *2 YH

*2

"7 ( ! ^ (, ? *;

N

E C ,

( 5!

. C

6 !

! ? *;

± /

&

/

&

(, ? *; ! {

/

&

U ±

/

&&

) HY / H

P>

.(

" ? *;

&

%

? *; *8 7

A 3 ! 3

B % 3 U

%

&V AB

% (, ? *; ! O

.*.

W X

% 3

&

% 3

%

&

% .

7 ! 6

$

$ p g 3

U

%

! 3

{ %

< * 9

?N 3

% 8 3 Y

% 6 3 Y

%

! | , b <

%

< : * 6

" _ ! (

.

*8 y 7 . 6 7 ! W A * < > ! " !

"( p g A 0 / * ;!

3 6. ST C * )

h / h (%

ST C *.!

3 6. A )

V / V .(%

tM8

! U

% 7

" ! 3

7 E] 8 M

*8 * !

?

! tM8 Y

%

" ! 3

<#

. !#

" 65 ( 8 ? * , 0!

.

7 ! , * , 6 /, *;

0 4

A, B, AB, )

( O

! # " 7# . Rh

0

Chi-Square

Y

7 e

* ( #

:

/, *; C 0

4

! 0 D E.!

6 0!

) HY /

P< H 3 VY / h

2

= .(

> ! C /, *;

0

A, B, AB O

( ( E T ; ( ! k :

? *; C 6 > ! A

0!

( ) / H

P = 3 }

df = 3 QZ /

~

2

= (.

? *; C 6 > ! B

0!

) HY / H

P<

3 }

= 3 df

[Q /

~

2

= (.

? *; C 6 > ! AB

0!

( ) Y /

P< H 3 }

df = 3 P}

/

~

2

= (.

? *; C 6 > ! O

0!

( ) X / H

P<

3 }

= 3 df

[[

/ P

2

= (.

! W .*. (, ! ? *; *8 Rh

VU

% V

%

^ E] 3 !

6 0! # *+ 7 B C

E !

) HY / H

P>

3

• / [

2

= (.

% &

! , * , < > C

; , * /

A 0

B 3

O 3

Rh

( !*

.

< > " 6 .

0 ( 1

6 7 C !

1 ! N; C < ?( F G

! C !

t .

Singh Shanker

F 5 ( ) ( . < > r, "# 7 (

?( F G

! * !

N €L 6 e

(

)

&

% Y (.

< > ! 0

! 0 UH

! 8*; F G

3

D E.!

! 0 r

MNSS, Keil, Rh,

ABO Duffy

" , 0 ,* _ 9

:

! 0 UH

!

3(,

!*

! G

•5 4 d D E.! " * (

6

! C r

*; MN

( ) Y .(

< > !

! ` , Das

"

3

* !

* : 0 . D E.! C

0 ,* _

F 9 ?( 6

3

! Xh

%

! 3 6 7 ,

6 7 x! 8 0

! d. ! 0 * ‚ 9

^ C 6m , < > C !

, * , h

* _

‚ 8* ` 9

!

! *L !*

8*;

4 d D E.!

C

* _

ACP1

( 8 Rh

) h .(

$

$ p g

< > ! 1! 4 *@ A

* 7 :

U %

! 3 {

%

< * 9

?N 3

% 8 3 Y

%

6 3 Y

%

*8 , b <

%

< : * 6

^ 6

* C

$

< * 9 ?N

* C F*8 .

!

1 < > *

< * 9 F*8 N

?N ) (A ! *.ƒ (4! E<

Yh (%

" 65

* ?( „! N; F*8 C )

U (.

! C

< >

3 7 ! , * , 6 /, *;

0 4

)

A , B , AB ,O

( 3 Rh

6 D E.!

! 0 C

/, *;

0 4

! (B)

0

D E.!

Rh C 6

! E

C B * ^

3 8

< > !

Kareemullah

" ! ` , 3 HHH

!

!* ! (,

, (6 8*; ! *L

> ! …

6

! 0 C /, *;

0 (_ „! N;

) V (

^

< > ! C 6m ,

Olasode

0 ! * hH E !

"# M hHHH

F G r< " ?(6, *8

( M D E.! N r

/, *; C 0

4 3 A

3 B O

! 0

„! N;

(_

) H .(

0* < > !

8 M C

!

? *; $

O

6 > ! Rh

! 0

< ( #

C 0!

/, *;

0

A,B,O Rh

6 > !

! 0 (

) V3U (.

†*

.

=*>

0! -. "(

, ( ( 0 3 1 < >

6 7 ! 0( ( 0 ,(6 *8

‚ 9 .

?( F G

"# 7 0! -. " .

b*

( .

) h

% V ( C

7 # ,

, ) { (

! * i.

*G6 ,( w < r <

< 8 ! .ƒ

# N

?( * ; , 0 (

)

&H (

* ?!

^

‚ !

h

< >

!

&HHY 7 * !

!* / C D E.!

"9 # r 8*

ctla-4 A49G

0 ,

T

0! ‚ .

( F G 3

*

* B

" . 0 / ! 3

6 7 C ! k E.! … , C

# C r 8*

"9 0!

„! N;

(_

)

&

(.

N " * ! D E.! 6 7 !

C /, *;

0

?( F G < >

.

‚ !

< >

!

8*; F G " */. 07 ! " ! 3

(6

< >

3*@ A ? *;

* _ (4! B

3

" ! C ! ! B C * _

M !

< > B * (, ? *;

*@ A C

7 B *+

G ! E ! 6 0! #

3 k E.! … ,

C /, *;

0 (_ „! N;

)

&&

(.

< > !

* 0

" * ! N

C k E.! … , /, *;

0

(_ 8

8 M C

? *;

6 D E.! O

0!

( # )

&

(.

.

4 . p g 1 < > ! 1 2 e

> ‚

<

* ; 1! 4 6 7 C ! 0! * N < # .

' ( )

8 , " _ < > C 0 ? *; *8

B

0 /, *; * E *.(

0 *

0!

< (6 C

! 0

> ! Rh

6

! 0

! ( .

*& + :

1- Burns T, Cox N. Rook textbook of dermatology. 7^thed. New York: Blackwell; 2004.

2- Naumder PP, Nordiland Y, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993; 129 (8):

994-98.

3- Nath SK, Naumder PP, Nordiand Y. Genetic Epidemiology of vitiligo. Am Hum Genet. 1994; 55(5): 980-90.

4- Kasper A, Braunwald C, Fauci K. Harrison Principles of internal medicine. 16^th ed. New York :Mc Graw Hill; 2005.

5- Abadie MSK, Warren MA, Bleehen SS. Gaw krodyer-ds, morphologic, observation on the dermal nevus in vitiligo and ultrastrcutural study. INT J Dermatol. 1995; 34(12): 837-40.

6- Das SK, Maumder PP, Majuder TK, Halder BT. Studies on vitiligo familial aggregation and generic so. Gent Epidemiol. 1985; 6 (2-3): 255-62.

7- Mohan L, Singh G, Kaur P, Pandey SS, Mohan R, Niyogi AK. ABO blood groups and vitiligo. Indian J Dermatol.

1982; 27(2): 60-62.

8- Kareemullah L, Tanjau V, Beyum S, Sarma PK, Baig HA. Association of ABO blood groups and vitiligo. J Med Genet. 1997; 14 (3): 211-13.

9- Wasfi AI, Saha N, EI Sheik FS, Ahmed MA. Generic association in vitiligo: ABO, MNSS, rhesus, kell and dufy blood groups. Clin Genet. 1980; 17 (6); 415-17.

10- Olasode OA. Is ABO blood grouping a gene marker for vitiligo? Niger J Med. 2002; 11(4): 193-95.

11- Singh G, Shanker P. Vitiligo and blood groups. Preliminary report. Br J Dermatol. 1966; 78 (2): 91-92.

12- Sehgal VN, Dube B. Ecretion of blood group specific substances in saliva of vitiligo patients. A preliminary report.

Br J Dermatol. 1967; 79 (12): 704-705.

13- Sehgal VN, Dube B. ABO blood groups and vitiligo.J Med Genet. 1968; 5(4):308-309.

14- Dutta AK, Mondal SB, Dutta SB. ABO blood group and secretary status in vitiligo. J Indian Med Assoc. 1969;

53(4):186-89.

15- Oriente BC, Ruocco V. Vitiligo and blood groups. Rass Int Clin Ter. 1969; 49(22):1395-99.

U

16- Schallreuter KU, Gibbons NC, Zothner C. Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun. 2006; 349(3):931-38.

17- Ines D, Sonia B. A comparative study of oxidant-antioxidant status in stable and active vitiligo patients.

Arch Dermatol Res. 2006; 298(4):147-52.

18- Schallreuter KU, Chiuchiarelli G. Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo. J Invest Dermatol. 2006 ; 126(5):1036-42.

19- Trcka J, Kunz M. Functional genome and proteome analyses of cutaneous autoimmune diseases. Curr Pharm.

2006;12(29):3787-98.

20- Dell'anna ML, Picardo M. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 2006 ;19(5):406-11.

21- Fatthi MJ, Pezeshki AB, Ghaderi A. Lack of association between ctla-4 A49G polymorphism and vitiligo. IJI. 2005;

2(2): 103-98.

~~

% g <

F

" L x

3 .

, *; $ 6. !*

/

A,B,O 0

E

! ! Rh

.

! 6 d8

/

0 .

U{

^

X

)

X

(:

% h

.

&

v 6 (<

b rG5 3 F

.

, *; !

7 *

*8

/

p g

0

.

5 6 d8 3! *

%

! NE ` N

F 5 ?(`_

_, q

.

U{

^

U

) :(

U

%

UV

.

V

Title: Association of A, B, O and Rh blood groups with Vitiligo Authors: R. Ghaderi¹

, A. Alipour

²

Abstract

Background and Aim: Vitiligo is an acquired depigmentary dermatitis on an otherwise normal skin, which

involves 1-2% of general population. Despite Various hypotheses and theories postulated, its etiology remains unknown. Genetic factors and blood groups seem to be implicated, to some extent, in the etiology of the disorder. This study was done to determine the association of Vitiligo with A, B, O blood groups and Rh.

Materials and Methods: In this case control study two groups were compared; one with 100 Vitiligo cases

and the other (the control group) consisting of 100 patients without the disorder in the dermatology clinics of Birjand. Then, blood groups and Rh of both groups were determined. Incidence of each blood group among patients was compared with that of the control group. Data were analyzed by SPSS package, using t and chi- square tests.

Results: Blood groups A, B, AB, and O in Vitiligo cases were found to be, 32%, 33%, 7% and 28%; while

they were 43%, 21%, 13% , and 23% in the controls, respectively. Thus, the differences were significant (

²

=6.85, P<0.05). The incidence of Rh positive and Rh negative blood groups in Vitiligo cases were found to be 87% and 13% compared to 83% and 17% in the controls respectively, but these differences weren't significant (

²

=6.7, P>0.05).

Conclusion: The results obtained through this study show that subjects with blood group B are more

susceptible to Vitiligo as compared to those with other groups but there is no significant association of Vitiligo with Rh.

Key Words: Vitiligo; Blood groups; Rh

1Corresponding Author; Associate Professor, Department of Dermatology; Faculty of Medicine, Birjand University of Medical Sciences. Birjand, Iran rezaghaderi@yahoo.com

2Legal Medicine Organization of Mashhad